Trump expected to link autism to Tylenol use during pregnancy
The Trump administration is poised to announce a potential link between autism and maternal use of Tylenol (acetaminophen) during pregnancy on Monday, according to the U.S. news outlet Axios. This move would reignite a medical theory that many experts in the field have previously refuted.
- Americas
- Anadolu Agency
- Published Date: 11:23 | 22 September 2025
US President Donald Trump and top health officials are expected to announce Monday that autism may be linked to the use of Tylenol, also known as paracetamol or acetaminophen, during pregnancy, reviving a medical controversy dismissed by many experts, according to the US news outlet Axios.
First reported by the Wall Street Journal earlier this month, the suggested link would reignite debate over the use of acetaminophen, Tylenol's active ingredient, during early pregnancy.
Health Secretary Robert F. Kennedy Jr., who has previously promoted debunked theories about autism, said a government report on the disorder's causes would be released this month.
In a statement, Kenvue, the maker of Tylenol, said: "We believe independent, sound science clearly shows that taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise and are deeply concerned with the health risk this poses for expecting mothers."
- Trump 'aware of' Putin's nuclear treaty extension offer: White House
- $100B trade volume target between Türkiye, US 'continues to be our common goal': President Erdoğan
- Trump to sign order designating Antifa a terrorist organization 'as soon as today'
- Trump to hold multilateral meeting with leaders of majority-Muslim nations on Tuesday: White House
- US could hit entire International Criminal Court with sanctions soon - sources